Cargando…

Adherence to Tumor Board Recommendations in the Treatment of Patients with Hepatocellular Carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is a heterogeneous disease that typically arises in the setting of chronic liver disease, making treatment selection complex. Multidisciplinary liver tumor boards (MDLTB) have been shown to improve outcomes in patients with HCC. However, in many cases, pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Yueming, Mezzacappa, Catherine, Jaffe, Ariel, Strazzabosco, Mario, Taddei, Tamar H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239642/ https://www.ncbi.nlm.nih.gov/pubmed/37283950 http://dx.doi.org/10.2147/JMDH.S407908

Ejemplares similares

Adherence of head and neck squamous cell carcinoma patients to tumor board recommendations
por: Rangabashyam, Mahalakshmi S., et al.
Publicado: (2020)

Using Telemedicine to Facilitate Patient Communication and Treatment Decision-Making Following Multidisciplinary Tumor Board Review for Patients with Hepatocellular Carcinoma
por: Choi, Debra T., et al.
Publicado: (2022)

Guideline adherence of tumor board recommendations in lung cancer and transfer into clinical practice
por: Walter, Julia, et al.
Publicado: (2023)

Guideline adherence and implementation of tumor board therapy recommendations for patients with gastrointestinal cancer
por: Krause, Alina, et al.
Publicado: (2022)

Adherence to BCLC recommendations for the treatment of hepatocellular carcinoma: impact on survival according to stage
por: Kikuchi, Luciana, et al.
Publicado: (2017)

Recognition of and treatment recommendations for oligometastatic disease in multidisciplinary tumor boards
por: Christ, Sebastian M., et al.
Publicado: (2022)

Adherence to interdisciplinary tumor board recommendations as an expression of quality-assured patient care: results of a bicentric German analysis
por: Braulke, Friederike, et al.
Publicado: (2023)

A Learning Program for Treatment Recommendations by Molecular Tumor Boards and Artificial Intelligence
por: Sunami, Kuniko, et al.
Publicado: (2023)

Attacking the public health crisis of hepatocellular carcinoma at its roots
por: Lee, Hannah M., et al.
Publicado: (2023)

Cross-sectional increase of adherence to multidisciplinary tumor board decisions
por: Hollunder, S., et al.
Publicado: (2018)

Development and Implementation of Multidisciplinary Liver Tumor Boards in the Veterans Affairs Health Care System: A 10-Year Experience
por: Rabiee, Atoosa, et al.
Publicado: (2021)

Diabetes medications and risk of HCC
por: Plaz Torres, Maria Corina, et al.
Publicado: (2022)

Artificial intelligence and lung cancer treatment decision: agreement with recommendation of multidisciplinary tumor board
por: Kim, Min-Seok, et al.
Publicado: (2020)

Impact of GI Tumor Board on Patient Management and Adherence to Guidelines
por: AlFarhan, Haneen A., et al.
Publicado: (2018)

Surveillance for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease: Universal or Selective?
por: Plaz Torres, Maria Corina, et al.
Publicado: (2020)

Sorafenib prescribed by gastroenterologists and hepatologists for hepatocellular carcinoma: A retrospective, multi-institutional cohort study
por: Kaplan, David E., et al.
Publicado: (2018)

Immune checkpoint inhibitors in malignancies after liver transplantation: A systematic review and pooled analysis
por: Kayali, Stefano, et al.
Publicado: (2022)

Concordance Between Recommendations From Multidisciplinary Molecular Tumor Boards and Central Consensus for Cancer Treatment in Japan
por: Naito, Yoichi, et al.
Publicado: (2022)

CD8+ T cell trajectory subtypes decode tumor heterogeneity and provide treatment recommendations for hepatocellular carcinoma
por: Liu, Long, et al.
Publicado: (2022)

Changes in Hepatocellular Carcinoma Surveillance and Risk Factors for Noncompletion in the Veterans Health Administration Cohort During the Coronavirus Disease 2019 Pandemic
por: Mahmud, Nadim, et al.
Publicado: (2021)

Establishment of a Molecular Tumor Board (MTB) and Uptake of Recommendations in a Community Setting
por: VanderWalde, Ari, et al.
Publicado: (2020)

Improved performance and consistency of deep learning 3D liver segmentation with heterogeneous cancer stages in magnetic resonance imaging
por: Gross, Moritz, et al.
Publicado: (2021)

The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma
por: Sellers, Cortlandt M., et al.
Publicado: (2021)

Sudden Unexpected Infant Death: Review and Analysis of Adherence to Recommendations
por: Konstat-Korzenny, Enrique, et al.
Publicado: (2019)

The impact of socioeconomic status on outcomes in hepatocellular carcinoma: Inferences from primary insurance
por: Sellers, Cortlandt M., et al.
Publicado: (2019)

Evaluation of leucocyte adherence inhibition in hepatocellular carcinoma.
por: Dusheiko, G. M., et al.
Publicado: (1979)

Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness
por: Brivio, Simone, et al.
Publicado: (2017)

Multicenter Comparison of Molecular Tumor Boards in The Netherlands: Definition, Composition, Methods, and Targeted Therapy Recommendations
por: Koopman, Bart, et al.
Publicado: (2020)

Leveraging the Multidisciplinary Tumor Board for Dissemination of Evidence-Based Recommendations on the Staging and Treatment of Gastric Cancer: A Pilot Study
por: Mehta, Shivani N., et al.
Publicado: (2022)

Systematic literature review of trials assessing recommended systemic treatments in hepatocellular carcinoma
por: Ronnebaum, Sarah, et al.
Publicado: (2021)

Recommended Papers of 2021 From the TMR Editorial Board
por: Dzik, Sunny, et al.
Publicado: (2022)

Case presentation and recommendations from the April 2018 ITMIG tumor board: an international multidisciplinary team
por: Sigurdson, Samantha S., et al.
Publicado: (2019)

Case presentation and recommendations from the April 2019 ITMIG tumor board: an international multidisciplinary team
por: Sigurdson, Samantha, et al.
Publicado: (2019)

Transcatheter Treatment of Hepatocellular Carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): Technical Recommendations
por: Lencioni, Riccardo, et al.
Publicado: (2011)

Predictors of Adherence to Lifestyle Recommendations in Stroke Secondary Prevention
por: Lennon, Olive, et al.
Publicado: (2021)

Lifestyle and Hepatocellular Carcinoma What Is the Evidence and Prevention Recommendations
por: Zelber-Sagi, Shira, et al.
Publicado: (2021)

Variation Between Multidisciplinary Tumor Boards in Clinical Staging and Treatment Recommendations for Patients With Locally Advanced Non-small Cell Lung Cancer
por: Hoeijmakers, Fieke, et al.
Publicado: (2020)

Five recommendations for loco-regional treatments of hepatocellular carcinoma during the COVID-19 pandemic
por: Santambrogio, Roberto, et al.
Publicado: (2020)

Consensus of Minimally Invasive and Multidisciplinary Comprehensive Treatment for Hepatocellular Carcinoma – 2020 Guangzhou Recommendations
por: Chen, Qi-Feng, et al.
Publicado: (2021)

Evaluation of ATLAS and CMS technical proposals, and recommendations to the Research Board
por: CERN. Geneva. The LHC experiments Committee
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_s3mdc6prapk8ldgcl6mj3l1ltg